Pharmaceutical Executive
How a broader “value” understanding can benefit brand teams.
Pharmaceutical Executive-12-01-2015
Pharmaceutical Executive
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
Pharmaceutical Executive
Pharm Exec talks with David Dosa, a leading physician in geriatric medicine, whose famous work with a cat named oscar in end-of-life diagnostics became the stuff of therapeutic legend.
Pharmaceutical Executive
A Pharm Exec conversation with AmerisourceBergen CEO Steve Collis
Pharmaceutical Executive
Drug pricing backlash threatens regulatory reform, R&D advances
Pharmaceutical Executive
A new discipline-population health-contests disease treatment as an end in itself. It asks: besides advancing the science of medicine, what do biopharmaceuticals actually do to improve health overall?
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
